Privia Health Group, Inc.

NasdaqGS:PRVA Stock Report

Market Cap: US$2.7b

Privia Health Group Past Earnings Performance

Past criteria checks 2/6

Privia Health Group has been growing earnings at an average annual rate of 36.1%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 20.2% per year. Privia Health Group's return on equity is 2.1%, and it has net margins of 0.7%.

Key information

36.1%

Earnings growth rate

35.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate20.2%
Return on equity2.1%
Net Margin0.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Aug 16
There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Recent updates

After Leaping 32% Privia Health Group, Inc. (NASDAQ:PRVA) Shares Are Not Flying Under The Radar

Nov 08
After Leaping 32% Privia Health Group, Inc. (NASDAQ:PRVA) Shares Are Not Flying Under The Radar

There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Nov 04
There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)

Sep 12
It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)

There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Aug 16
There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Jul 12
Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity

Jun 11
Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity

Privia Health: Key Lessons Learned (Rating Downgrade)

May 22

Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

Mar 03
Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

Feb 27
The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Jan 31
There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Dec 03
Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Nov 06
Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Aug 08
Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Mar 17
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Privia Health: In Line For Solid FY22, Hold On Valuation

Sep 15

Privia Health Group reports Q2 earnings beat; raises FY22 outlook

Aug 11

Privia Health Group Grows But Operating Results Await

Jun 20

Revenue & Expenses Breakdown

How Privia Health Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:PRVA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,716131460
30 Jun 241,696151430
31 Mar 241,687191400
31 Dec 231,658231330
30 Sep 231,581381290
30 Jun 231,507341310
31 Mar 231,429161370
31 Dec 221,357-91460
30 Sep 221,268-381590
30 Jun 221,176-491600
31 Mar 221,066-2113020
31 Dec 21966-1882790
30 Sep 21905-1722540
30 Jun 21860-1472280
31 Mar 2181831590
31 Dec 2081731550
31 Dec 197868510
31 Dec 18658-3530

Quality Earnings: PRVA has high quality earnings.

Growing Profit Margin: PRVA's current net profit margins (0.7%) are lower than last year (2.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PRVA has become profitable over the past 5 years, growing earnings by 36.1% per year.

Accelerating Growth: PRVA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PRVA had negative earnings growth (-66.3%) over the past year, making it difficult to compare to the Healthcare industry average (10.3%).


Return on Equity

High ROE: PRVA's Return on Equity (2.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies